.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Cipla
McKinsey
Queensland Health
AstraZeneca
Merck
Novartis
Colorcon
Chubb

Generated: December 12, 2017

DrugPatentWatch Database Preview

Drug Master Files for: AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
247I3/14/1957NORDSON PHARMACEUTCAL LABS INCLEVONOR (1-AMPHETAMINE ALGINATE)
1079I9/6/1967NYSCO LABS INCDEXTRO-AMPHETAMINE SULFATE
2314AII8/8/1974BOEHRINGER INGELHEIM CHEMICALS INCAMPHETAMINE BULK AND DEXTRO DESOXYEPHEDRINE
2604III2/19/1976JOHNSON MATTHEY PHARMACEUTICAL MATERIALSAMPHETAMINE SULFATES
4402III12/23/1981LONZA RIVERSIDEHYDROXYAMPHETAMINE HYDROBROMIDE
4818III1/12/1983MEDI PHYSICS INC1231-M-123 OR 1231-d,1-N-ISOPROPYL-P-IODOAMPHETAMINE HYDROCHLORIDE
5378III2/9/1984SIGMA F AND D DIV LTDD-AMPHETAMINE SULFATE # A5880 FD & (+) METHAMPHETAMINE HCL NO. M8750FD
6293AV4/24/1986MULTIDISCIPLINARY ASSN PSYCHEDELIC STUDIESMDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) IN RATS AND DOGS
10334AII7/6/1993CHATTEM CHEMICALS INCHYDROXYAMPHETAMINE HYDROBROMIDE USP
11412IV3/28/1995PHARMACO LIFE SCIENCE RESEARCHMETHOD GC32,GC ANALYSIS OF SELEGILINE IN HUMAN PLASMA AND METHOD GC33 REVISION 1, GC ANALYSIS OF AMPHETAMINE METHAPHETAMINE AND DESMETHYSELEGILINE IN HUMAN PLAS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
US Department of Justice
Accenture
Harvard Business School
Citi
Dow
Mallinckrodt
Argus Health
Baxter
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot